scholarly article | Q13442814 |
P2093 | author name string | Tishler M | |
Yaron M | |||
Raz A | |||
Yaron I | |||
Meyer FA | |||
P2860 | cites work | Measurement of whole unstimulated salivary flow in the diagnosis of Sjögren's syndrome | Q33564543 |
Criteria for the salivary component of Sjögren's syndrome. A review | Q38648912 | ||
Identification and quantitation of arachidonic-acid metabolic products in rabbit, rat and human saliva | Q42246739 | ||
Concentrations of arachidonic-acid metabolites in human mixed saliva are independent of flow rate | Q42252433 | ||
Salivary prostaglandin concentrations: possible state indicators for major depression | Q46191091 | ||
Human salivary eicosanoids: circadian variation | Q49106097 | ||
T cell subpopulations in the labial minor salivary gland histopathologic lesion of Sjögren's syndrome | Q52101036 | ||
Prostaglandins E2 and E2 alpha are elevated in saliva of cystic fibrosis patients | Q69801343 | ||
Paradoxical conservation of cardiac and renal arachidonate content in essential fatty acid deficiency | Q69972789 | ||
Preliminary criteria for the classification of Sjögren's syndrome. Results of a prospective concerted action supported by the European Community | Q70607945 | ||
Labial salivary gland biopsy in Sjögren's syndrome. Assessment as a diagnostic criterion in 362 suspected cases | Q71269650 | ||
Sialochemistry for diagnosis of Sjögren's syndrome in xerostomic patients | Q72024163 | ||
P433 | issue | 3 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | Sjögren's syndrome | Q335555 |
P304 | page(s) | 202-204 | |
P577 | publication date | 1996-03-01 | |
P1433 | published in | Annals of the Rheumatic Diseases | Q4767876 |
P1476 | title | Salivary eicosanoid concentration in patients with Sjögren's syndrome | |
P478 | volume | 55 |
Q41434699 | Acute salivary gland hypofunction in the duct ligation model in the absence of inflammation |
Q83910666 | Association between obesity, flow rate of whole saliva, and dental caries in adolescents |
Q43949872 | Dietary fat and salivary prostaglandin E2. |
Q77668707 | Essential fatty acid status in cell membranes and plasma of patients with primary Sjogren's syndrome. Correlations to clinical and immunologic variables using a new model for classification and assessment of disease manifestations |
Q73310093 | Expression of cyclooxygenase-1 (COX-1) in labial salivary glands of Sjögren's syndrome |
Q35672964 | Measurement of C-reactive protein, procalcitonin and neutrophil elastase in saliva of COPD patients and healthy controls: correlation to self-reported wellbeing parameters |
Q34480847 | Saliva--a diagnostic window to the body, both in health and in disease |
Q41683419 | Saliva: an additional diagnostic tool in Sjögren's syndrome |
Q48768244 | Standardized assessment of disease status in patients with primary Sjögren's syndrome: the foundation for creating criteria for disease activity and damage? |
Q34720733 | The diagnostic applications of saliva--a review |
Search more.